BANJARMASINPOST.CO.ID – The pharmaceutical giant AstraZeneca and Oxford The university said it had resumed trials of the Covid-19 vaccine on Saturday (13/9/2020), after receiving approval from British regulators.
“Clinical trials for the AstraZeneca Oxfor coronavirus vaccine, AZD1222, have continued in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA) that it is safe to carry out,” the company said in a statement. ).
On Wednesday (9/9/2020), AstraZeneca announced it was suspending trials of the coronavirus vaccine after a volunteer fell ill.
An independent committee designed to review the safety of vaccine trials has concluded its investigation and recommended that the MHRA continue trials.
Party Oxford The university has also confirmed that coronavirus vaccine trials are resuming.
“In a large trial like this, it is expected that some of the participants will become unwell and each case must be carefully evaluated to ensure a careful safety assessment,” said Oxford in a statement.
Although it was stopped, AstraZeneca hopes the vaccine will be available at the end of this year or early next year.
However, many pharmaceutical companies, including AstraZeneca and scientists, expressed concern about political pressure to release a vaccine immediately.
Lose control
The AstraZeneca vaccine candidate is one of nine vaccines worldwide currently in Phase 3 trials in humans.
–
